PMX 205
| Code | Size | Price |
|---|
| TAR-T12506L-5mg | 5mg | £850.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃
Documents
Further Information
Bioactivity:
PMX 205 is an effective complement antagonist of the C5a receptor.
CAS:
514814-49-4
Formula:
C45H62N10O6
Molecular Weight:
839.055
Purity:
0.98
SMILES:
[H][C@@]12CCCN1C(=O)[C@]([H])(CCCNC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@]([H])(Cc1c[nH]c3ccccc13)NC(=O)[C@@H](CC1CCCCC1)NC2=O)NC(=O)CCc1ccccc1
References
1. Kosni NN, et al. Expression of complement C5a receptor and the viability of 4T1 tumor cells following agonist-antagonist treatment. J Cancer Res Ther. 2016 Apr-Jun;12(2):590-6.
2. Woodruff TM, et al. The complement factor C5a contributes to pathology in a rat model of amyotrophic lateral sclerosis. J Immunol. 2008 Dec 15;181(12):8727-34.
3. Fonseca MI, et al. Treatment with a C5aR antagonist decreases pathology and enhances behavioral performance in murine models of Alzheimer's disease. J Immunol. 2009 Jul 15;183(2):1375-83.